Johnson & Johnson (NYSE: JNJ) is a top stock discussed by Jim Cramer. He praises their strong franchises and upcoming spinoff. JNJ is known for healthcare products and medical technologies, focusing on high-growth pharma. Cramer believes the company’s strategic moves make it a solid investment choice.

While JNJ shows promise, other AI stocks may offer better returns with less risk. Consider exploring undervalued AI stocks that may benefit from current economic trends. For more insights on AI investments, check out our free report on the best short-term AI stock.

Looking for potential stock doubles in the next three years? Discover 30 stocks with that potential and explore 11 hidden AI stocks worth buying now. Stay informed and make strategic investment decisions for the future.

Read more at Yahoo Finance: Jim Cramer Says He is “Particularly Fond” of Johnson & Johnson